Clinical Trial Update: Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)

View source ↗

Summary

This clinical trial is recruiting to assess whether high-sensitivity troponin I, NT-proBNP, and soluble ST2 can predict mortality and cardiovascular events in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani | Conditions: Type 2 Diabetes, Cardiovascular Complication | Status: RECRUITING